Immune Repertoire Sequencing Market Regional Analysis:
North American Market Insights
North America region is anticipated to hold over 40.8% market share by 2035. This can be ascribed to the high health spending, and strong presence of market players in the region, especially in the United States and Canada. According to the Centers for Medicare & Medicaid Services (CMS), health spending in the United States grew by 9.7% in 2020, reaching a value of USD 4.1 trillion, or USD 12,530 per person. The market is also anticipated to grow with escalating demand for immunotherapy for cancer and other infectious diseases.
APAC Market Statistics Insights
The immune repertoire sequencing market in the Asia Pacific region is estimated to observe noteworthy market demand throughout the estimated period. This can be attributed on the back of the increasing number of international collaborations for immune repertoire sequencing in the region.
In addition, the focus of countries, namely China and Japan, on the integration of new technologies in the healthcare sector is also expected to drive market growth significantly in the coming years.
